Background: Endometrial cancer is the most common gynecologic malignancy worldwide. Polymorphisms in MALAT1 have been demonstrated to play critical roles in cancer. However, the roles of MALAT1 polymorphisms in the etiology of endometrial cancer have not been well documented.
Methods:We genotyped three MALAT1 polymorphisms in 249 endometrial cancer cases and 446 cancer-free female controls using quantitative polymerase chain reaction with TaqMan probes. To estimate the association between MALAT1 polymorphisms (rs591291 C>T, rs664589 C>G, and rs4102217 G>C) and the risk of endometrial cancer, an unconditional logistic regression model was conducted to calculate the odds ratio (OR) and the 95% confidence interval (CI), adjusting for surgery history, menopause, number of deliveries, BMI, and FIGO stage.
Results:We found that the MALAT1 rs664589 C>G polymorphism was significantly associated with endometrial cancer risk (heterogeneous: adjusted OR = 0.57, 95% CI = 0.34-0.93, P = .026; homogenous: adjusted OR = 3.74, 95% CI = 1.12-12.45, P = .032; and recessive: adjusted OR = 4.06, 95% CI = 1.22-13.48, P = .022). Stratified analysis further demonstrated that the MALAT1 rs664589 C>G polymorphism significantly increased the risk of endometrial cancer susceptibility in patients with no history of surgery, more deliveries, BMI between 25 and 29.9, and FIGO stages II-III.Compared with the wild-type GCG haplotype carriers, individuals with CGG haplotypes had a higher risk of developing endometrial cancer.
Conclusion:The MALAT1 rs664589 C>G polymorphism was associated with a significant increase in endometrial cancer risk. K E Y W O R D S endometrial cancer, MALAT1, risk, single nucleotide polymorphisms 2 of 7 | CHEN Et al.1 | INTRODUC TI ON Endometrial cancer (EC) is the most common cancer among females worldwide. 1 The incidence of EC has seen a significant increase in China. 2 Unopposed estrogen, early menarche, endometriosis, obesity, diabetes, late menopause, hypertension, and nulliparity are now well established as causative agents responsible for endometrial cancer. 3 Although these risk factors are strongly associated with the risk of endometrial cancer, only a small number of women eventually develop endometrial cancer, suggesting that host genetic variations play critical roles in endometrial cancer development.Long non-coding RNAs (lncRNAs) are a class of ncRNAs that are more than 200 nucleotides and are involved in several biological processes. [4][5][6][7][8] Increasing evidence suggests that lncRNAs are associated with tumor genesis, progress, and treatment response. 9,10 Metastasis associated with lung adenocarcinoma transcript-1 (MALAT1) is a long intergenic non-coding RNA (lincRNA), consisting of more than 8000 nts and located on chromosome 11q13. 11,12 Recent studies have shown that abnormal MALAT1 expression influenced cancer cell proliferation, invasion, and/or metastasis in various tumors, such as breast cancer, 13 lung cancer, 14 and gastric cancer. 15 Therefore, MALAT1 has been classified as an oncogene...